Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Rimmyrah 10 mg/ml solution for injection {equilateral_black_triangle}

Active Ingredient:
ranibizumab
Company:  
Orion Pharma (UK) Limited See contact details
ATC code: 
S01LA04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs Audio/Video
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Patient targeted, educational materials

{healthcare_pro_orange} For Healthcare Professionals
In line with the agreed Risk Management Plan for Rimmyrah 10 mg/ml solution for injection - PLGB 44570/0033, Qilu Pharma have developed a set of patient targeted, educational materials in order to support the safe use of ranibizumab.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Orion Pharma (UK) Limited
Company image
Address
9th Floor, The Blade, Abbey Square, Reading, RG1 3BE, UK
Telephone
+44 (0)1635 520 300
Medical Information e-mail
[email protected]
Out of Hours Telephone
+44 (0)1635 520 300
Adverse event reporting email
[email protected]
Stock Availability
orionukar&[email protected]
WWW
https://www.orionpharma.co.uk